Pemetrexed ADVAGEN approved in Singapore

October 07, 2020

ADVAGEN, a Singapore based company founded in 2006 which develops and markets healthcare supplements and pharmaceuticals, is pleased to announce its chemotherapeutic product, Pemetrexed ADVAGEN, is now approved in Singapore.

“We are pleased to be able to provide a wider range of safe, effective and affordable treatment options with the addition of Pemetrexed ADVAGEN in Singapore. We will continue to ensure timely supply of medicine for our patients and doctors.” – Koh, Director of ADVAGEN